Cutia Therapeutics Goes Public on SEHK
13 Jun 2023
US$ 19.00
Cutia Therapeutics (Cutia), a dermatology-focused biopharmaceutical company that counts 6 Dimensions Capital, Hony...
Related Publications
The Longreach Group (Longreach) announced the final closing of Longreach Capital Partners 4 (Longreach 4) at ......
Boost Capital, Global Catalyst Partners Japan, Gogin Capital, and Aichi Capital were party to the ¥2 billion (US$14...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.